Global healthcare leader sets up innovation center in SW China
Take me away, mom Animals on the Road	“Water Margin” on eggs Cat the occupier Adorable animals pose like stars Cuddle up together, battling against blizzard Sunshine in the life

 

French pharmaceutical company Sanofi signed a cooperation agreement with the Management Committee of Chengdu Hi-Tech Industrial Development Zone in southwest China's Sichuan Province to establish its Operation and Innovation Center.

As a major component of the facility, Sanofi will also launch a Global R&D Operations Hub in Chengdu with a specialized focus on digitalization and big data analysis.

The new R&D Operations Hub confirmed China as the third pillar of Sanofi Global Clinical Sciences and Operations, joining facilites in France and the United States.

With a total investment of 500 million yuan (about 75 million U.S. dollars), the Chengdu hub will support Sanofi's drug development by managing global multi-center clinical trial data and files.

The hub will recruit 300 local pharmaceutical R&D professionals by 2020 to take advantage of innovative local talent and further strengthen Sanofi's digital capabilities.

Sanofi China, established in 1982 with headquarters in Shanghai, has a wide range of businesses covering pharmaceuticals and human vaccines. At the end of 2016, Sanofi had over 9,500 employees in China.

The Chengdu Hi-Tech Industrial development Zone is one of the largest biopharmaceutical industry zones in central and west China. The high-tech zone has attracted more than 1,500 domestic and overseas biology-related companies with employees exceeding 35,000 as of 2017.

Author： 　　　Source：xinhua　　　 Editor：Yang Fan